Dinkelaar R B, Hart A A, Engels E Y, Schoemaker L P, Chamuleau R A, Bosch E
Exp Hematol. 1981 Aug;9(7):788-95.
It is a well recognized problem that sample derived transferrin-bound iron (Tf-Fe) interferes with radio-iron incorporation into heme in the in vitro assay of erythropoietin (Ep) using fetal mouse liver cells (FMLC). This paper describes a mathematical procedure to correct for the unknown quantity of "cold" Tf-Fe in a plasma sample, being assayed for Ep in the FMLC. Excellent recovery of Ep activity was obtained with this method of correction, when testing solutions containing Step III sheep Ep with and without human Tf-Fe. The distorted dose response curves, obtained, when testing specimens of rat plasma, showed, after correction, linearity and parallelism to a Step II Ep dose response curve, permitting valid estimation of the potency ratio. Reproducibility of this method was found to be excellent. Accuracy was acceptable with plasma samples containing more than 50 mU Ep/ml. The FMLC and the exhypoxic polycythemic mouse assay were compared using several batches of rat plasma. Good agreement was found between the results in both assays. As only a small amount of sample is needed (0.2 ml plasma) this method enabled us to estimate EP activity in single rats serially without disturbing their plasma volume significantly.
在使用胎鼠肝细胞(FMLC)进行促红细胞生成素(Ep)的体外测定中,样本衍生的转铁蛋白结合铁(Tf-Fe)干扰放射性铁掺入血红素,这是一个公认的问题。本文描述了一种数学方法,用于校正血浆样本中未知量的“冷”Tf-Fe,该血浆样本正在FMLC中进行Ep测定。当测试含有第三步绵羊Ep且有无人类Tf-Fe的溶液时,采用这种校正方法可获得优异的Ep活性回收率。在测试大鼠血浆样本时得到的扭曲剂量反应曲线,校正后显示出与第二步Ep剂量反应曲线的线性和平行性,从而能够有效估计效价比。发现该方法的重现性极佳。对于每毫升含有超过50 mU Ep的血浆样本,准确性是可接受的。使用几批大鼠血浆比较了FMLC和低氧性红细胞增多症小鼠测定法。两种测定结果之间发现有良好的一致性。由于仅需要少量样本(0.2 ml血浆),该方法使我们能够连续估计单只大鼠的Ep活性,而不会显著干扰其血浆量。